Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF
- 1 October 2016
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 205, 105-109
Abstract
No abstract availableKeywords
All Related Versions
This publication has 32 references indexed in Scilit:
- États des lieux et expertise de l’usage hors AMM du méthotrexate en gynécologie–obstétrique : travail du CNGOFJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2015
- Fertility after ectopic pregnancy: the DEMETER randomized trialHuman Reproduction, 2013
- MethotrexateClinical Obstetrics and Gynecology, 2012
- Teratogen update: MethotrexateBirth Defects Research Part A: Clinical and Molecular Teratology, 2012
- The Levels of Evidence and Their Role in Evidence-Based MedicinePlastic and Reconstructive Surgery, 2011
- Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysisHuman Reproduction Update, 2008
- Is routine monitoring of hepatic and renal function beneficial following single-dose methotrexate treatment for ectopic pregnancy? A 4-year review of experience from a teaching hospitalJournal of Obstetrics and Gynaecology, 2008
- Prophylactic methotrexate after linear salpingostomy: a decision analysisFertility and Sterility, 2001
- Methotrexate Prophylaxis for Persistent Ectopic Pregnancy After Conservative Treatment by SalpingostomyObstetrics & Gynecology, 1997
- Low-dose oral methotrexate with expectant management of ectopic pregnancyObstetrics & Gynecology, 1996